Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Importance Several management strategies may improve outcomes in patients
withStaphylococcus aureusbacteremia. Objectives To review evidence of management …

Staphylococcus aureus bacteremia (SAB) is an important infection with an incidence rate
ranging from 20 to 50 cases/100,000 population per year. Between 10% and 30% of these …

Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-and
community-associated infections worldwide. Within the healthcare setting alone, MRSA …

Background. We assessed the impact of infectious disease (ID) consultation on
management and outcome in patients with Staphylococcus aureus bacteremia (SAB) …

Objectives Staphylococcus aureus bacteraemia is a common, often fatal infection. Our aim
was to describe how its clinical presentation varies between populations and to identify …

Objective Mortality and morbidity of Staphylococcus aureus bacteremia (SAB) still remains
considerably high. We aimed to evaluate the impact of infectious disease consultation (IDC) …

Los antimicrobianos son fármacos distintos al resto. Su eficacia en la reducción de la
morbilidad y la mortalidad es muy superior a la de otros grupos de medicamentos. Por otra …

Background. Staphylococcus aureus bacteremia (SAB) is associated with significant
morbidity and mortality. Several aspects of clinical management have been shown to have …

Purpose: To review the epidemiology of Staphylococcus aureus bacteraemia (SAB) and
endocarditis (SAE), and discuss the short-and long-term outcome. Materials and methods: A …